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Introduction
Tetraspanins are medium-sized ( 250 amino acids) membrane 
proteins that contain cytoplasmic NH2 and COOH termini and 
two extracellular domains separated from each other by a short 
inner loop. The mammalian family of these evolutionarily con-
served proteins contains 32 members. Tetraspanins are expressed 
in a wide range of tissues and cell types, and members of this 
protein family have been implicated in regulating various bio-
logical functions, including antigen presentation, cell adhesion 
and migration, cell–cell fusion, cell activation, and proliferation 
(for reviews see Berditchevski, 2001; Vogt et al., 2002; Hemler, 
2003; Stipp et al., 2003; Tarrant et al., 2003; Hemler, 2005).
Tetraspanins associate specifi  cally with distinct integrins, 
various Ig superfamily members, and other tetraspanins, thus 
establishing a scaffold for various cellular functions. Numer-
ous biochemical analyses and functional studies predicted the 
existence of tetraspanin-enriched microdomains (TEMs) that to-
gether form the so-called tetraspanin web (Charrin et al., 2003; 
Levy and Shoham, 2005). TEMs are thought to organize the 
plasma membrane and intracellular membranes, where some 
tetraspanins are primarily located, by selectively concentrating 
specifi  c membrane proteins and membrane-peripheral signaling 
molecules. Such TEM-based concentration/exclusion of proteins 
involved, for example, in adhesion or in intracellular signaling 
is thought to dynamically segregate molecules, similar to how 
lipid rafts are proposed to laterally organize cellular membranes. 
Although some studies have documented colocalization of indi-
vidual tetraspanins with various membrane receptors and costim-
ulatory molecules, e.g., in adhesion complexes (Berditchevski 
et al., 1997; Berditchevski and Odintsova, 1999), the concept that 
different members of the tetraspanin family associate at mem-
branes, thus forming distinct microdomains, is based largely on 
coimmunoprecipitation and protein cross-linking data. Neither 
the mean size of TEMs nor their overall distribution at the plasma 
membrane of these microdomains has been determined.
Human immunodefi  ciency virus type 1 (HIV-1), like other 
enveloped viruses, exits from cells by budding through mem-
branes, a process that does not lead to disintegration of the cell. 
For its budding, HIV-1 uses the host cell machinery that is respon-
sible for the formation of intralumenal vesicles in multivesicular 
bodies (MVBs), components of the endosomal compartment (for 
review see Morita and Sundquist, 2004). Nevertheless, HIV-1 
primarily buds through the plasma membrane of T lymphocytes 
and other cell types. Only in macrophages is HIV-1 known to bud 
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peciﬁ  c spatial arrangements of proteins and lipids 
are central to the coordination of many biological 
processes. Tetraspanins have been proposed to lat-
erally organize cellular membranes via speciﬁ  c associa-
tions with each other and with distinct integrins. Here, we 
reveal the presence of tetraspanin-enriched microdomains 
(TEMs) containing the tetraspanins CD9, CD63, CD81, 
and CD82 at the plasma membrane. Fluorescence and 
immunoelectron microscopic analyses document that the 
surface of HeLa cells is covered by several hundred TEMs, 
each extending over a few hundred nanometers and con-
taining predominantly two or more tetraspanins. Further, 
we reveal that the human immunodeﬁ  ciency virus type 1 
(HIV-1) Gag protein, which directs viral assembly and re-
lease, accumulates at surface TEMs together with the HIV-1 
envelope glycoprotein. TSG101 and VPS28, components 
of the mammalian ESCRT1 (endosomal sorting complex 
required for transport), which is part of the cellular extra-
vesiculation machinery critical for HIV-1 budding, are 
also recruited to cell surface TEMs upon virus expression, 
suggesting that HIV-1 egress can be gated through these 
newly mapped microdomains.
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exclusively into MVBs. Viruses sequestered in these late endo-
somes (LEs) are thought to exit from macrophages upon fusion 
of the limiting membrane of MVBs with the plasma membrane 
(Raposo et al., 2002; Pelchen-Matthews et al., 2003).
HIV-1 produced in macrophages specifi  cally incorporates 
the tetraspanin CD63, compatible with the fi  nding that this anti-
gen largely resides at the limiting membrane and on intralumenal 
vesicles of LEs/MVBs (Escola et al., 1998; Kobayashi et al., 
2000; Gruenberg, 2001; Rous et al., 2002; Pelchen-Matthews 
et al., 2003). However, despite its low abundance at the plasma 
membrane of cells, CD63 is also specifi  cally incorporated into 
HIV-1 particles produced in primary and transformed T lym-
phocytes and in other nonmacrophages where this virus buds 
mainly through the cell cortex (Orentas and Hildreth, 1993; Ott, 
2002). Furthermore, we previously reported that we occasion-
ally observed colocalization of HIV-1 Gag and CD63 at the 
  periphery of T lymphocytes and melanocytes, though it was 
 diffi  cult to distinguish with certainty between the small fraction 
of CD63 associated with the plasma membrane and the vast 
  majority of this antigen residing on intracellular membranes 
(Nydegger et al., 2003).
Here, we tested the hypothesis that the small fraction of 
CD63 that resides at the plasma membrane is concentrated at 
distinct microdomains, i.e., in TEMs, together with other mem-
bers of the tetraspanin family. Fluorescence microscopy analy-
sis of cells in which we selectively stained the surface fractions 
of tetraspanins combined with EM of immunolabeled sheets of 
plasma membrane allowed us to visualize TEMs containing the 
tetraspanins CD9, CD81, CD82, and CD63. Our data also docu-
ment the size and distribution of these TEMs in membranes. 
Furthermore, the data presented in this paper suggest that these 
newly visualized plasma membrane microdomains can function 
as exit gateways for HIV-1.
Results
Identiﬁ  cation of CD63-enriched 
microdomains situated 
at the plasma membrane
Although the tetraspanin CD63 is known to cycle via the cell 
surface, at steady state, the vast majority (>98%) of this anti-
gen resides in perinuclear LEs/MVBs of HeLa cells (Fig. 1 A). 
The overall distribution of CD63 is thus identical to what is seen 
in melanocytes and T lymphocytes (Nydegger et al., 2003) and 
other cell types (Stinchcombe and Griffi  ths, 1999; Kobayashi 
et al., 2000). To examine specifi  cally the cell surface distribution 
of CD63, we incubated HeLa cells with the antibody H5C6, 
whose epitope is located either in the small or in the large ex-
tracellular loop (EC1 or EC2, respectively) of this tetraspanin 
(Azorsa et al., 1991). After fi  xation and incubation with a sec-
ondary, fl  uorophore-conjugated antibody, cells were analyzed 
by widefi  eld fl  uorescence deconvolution microscopy (Gerlich 
and Ellenberg, 2003). Such selective staining of surface CD63 
in live cells revealed that the small fraction of this antigen that 
resides at the plasma membrane, rather than being diffusely dis-
tributed, clusters in discrete microdomains. To exclude the pos-
sibility that CD63 clustering was due to antibody cross-linking, 
cells were also stained after fi  xation in some experiments. Fig. 
1 B visualizes that discrete CD63 assemblages exist at the cell 
surface before antibody binding. These microdomains are not 
restricted to the adhesion structures but are present in the entire 
cell periphery, as shown in Fig. 1 B (bottom). Video 1 (available 
at http://www.jcb.org/cgi/content/full/jcb.200508165/DC1) 
shows a 3D-rendering of a cell surface stained for CD63 and 
visualizes that clusters of this antigen are equally abundant in 
those areas of the cell surface that are not contacting other cells 
or the plastic of the tissue culture dish. Fig. 1 C documents that 
the plasma membrane of an individual cell contains several hun-
dred CD63-enriched microdomains (mean number of domains 
per 25 μm
2 = 18 ± 4).
Partial colocalization of the tetraspanins 
CD9, CD81, CD82, and CD63: 
visualization of surface TEMs
Through biochemical studies, CD63 is known to associate with 
other members of the tetraspanin family (Rubinstein et al., 1996;
Figure 1.  Identiﬁ  cation of CD63-enriched microdomains at the surface of 
HeLa cells. HeLa cells were stained with an anti-CD63 antibody after ﬁ  xa-
tion and permeabilization (A; a middle section is shown) or after ﬁ  xation 
without permeabilization (B [middle and bottom sections are shown] and 
C [a bottom section is shown]), followed by incubation with a ﬂ  uorophore-
  conjugated secondary antibody. The selective staining of surface CD63 
(B and C) allows visualization of discrete microdomains where this antigen 
clusters at the plasma membrane. Bar, 10 μm. (C, right) Sevenfold-magniﬁ  ed 
view of the boxed region in the cell shown in the left panel. Bar, 1 μm.TEMS CAN FUNCTION AS GATEWAYS FOR HIV-1 • NYDEGGER ET AL. 797
Tarrant et al., 2003). We were interested in investigating 
the localization of CD9, CD81, and CD82, three tetraspanins 
that were previously shown to coprecipitate with CD63 in 
preB cells (Rubinstein et al., 1996) and two of which (CD81 
and CD82) were shown to associate with HIV-1 produced 
in MVBs of macrophages (Pelchen-Matthews et al., 2003). 
First, we sought to compare the overall distribution of these 
 tetraspanins. Cells were incubated with the respective  antibodies 
after permeabilization. Compared with CD63, the three other 
members of the tetraspanin family showed signifi  cantly 
higher surface expression (Fig. 1 A and Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200508165/DC1). 
Although some colocalization at intracellular membranes was 
observed for these tetraspanins (Fig. S1 B), at steady state, sub-
stantial fractions of those antigens apparently reside at different 
intracellular membranes.
Next, cells were stained for the plasma membrane fraction 
of the selected tetraspanin, as described in Fig. 1 B, and the rela-
tive colocalization of surface CD63 with CD9, CD81, or CD82 
was assessed. Substantial colocalization of CD63 with any one 
of the three tetraspanins was observed (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200508165/DC1), sug-
gesting that relatively large fractions of CD9 and CD82   reside 
in plasma membrane TEMs together with CD63, whereas a 
small fraction of total CD63 contributes to these surface 
  microdomains. The concept that various tetraspanins contribute 
Figure 2. CD9, CD63, CD81, and CD82 
  cocluster in surface TEMs. To identify surface 
TEMs containing three of the tetraspanins ana-
lyzed here, HeLa cells were surface stained as 
described in Materials and methods. Insets 
show sixfold-magniﬁ  ed views of the boxed re-
gion in the cell. The percentages of TEMs con-
taining one (30 ± 9), two (24 ± 7), or three 
(46  ± 14) of the tetraspanins visualized in 
these triple stainings were assessed as de-
scribed in Materials and methods (n > 300). 
Bar, 10 μm. JCB • VOLUME 173 • NUMBER 5 • 2006  798
dissimilarly to the formation of TEMs is based on biochemical 
studies only (for review see Hemler, 2003). The data presented 
in Fig. 2 and Fig. S2 support that concept and provide an 
  unprecedented visualization of bona fi  de surface TEMs.
Contribution of individual tetraspanins 
to the formation of surface TEMs
At the plasma membrane, CD63 typically colocalizes with one or 
more of the other three tetraspanins (Fig. S2). Also, CD9, CD81, 
and CD82 partially colocalize with each other (unpublished 
data). It follows that a subset of the TEMs visualized in Fig. S2 
contains at least three of the analyzed tetraspanins. In Fig. 2, we 
demonstrate that this is indeed the case. A detailed visual inspec-
tion of the three triple stainings revealed that more than two thirds 
of TEMs contain at least two of the three analyzed tetraspanins 
and about half of them contain all three antigens.
Although biochemical analyses (i.e., coprecipitation 
  experiments) allow determination of how much an individual 
tetraspanin contributes to an average TEM, such analyses of the 
bulk population do not permit determination of whether those 
relative contributions are uniform, i.e., whether tetraspanins 
  accumulate at TEMs in defi  ned ratios. The analysis of triple 
  immunostainings, however, can provide such information. The 
magnifi  cations in Fig. 2 (right) and Fig. 3 A visualize that the 
composition of TEMs at steady state varies widely, and the sta-
tistical analysis shown in Fig. 3 B documents that the tetraspan-
ins analyzed in this study do not exist in TEMs in distinct, 
uniform ratios. Note that TEMs containing only one or two of 
the three analyzed tetraspanins were excluded from this quanti-
fi  cation. TEM heterogeneity may thus be even larger than sug-
gested by the graph shown in Fig. 3 B.
Ultrastructural analysis of surface TEMs
The overall presence of CD63 at the limiting membrane of 
MVB and on intraluminal vesicles of MVBs has been well 
  documented previously by immuno-EM in various cell types 
(Escola et al., 1998; Pelchen-Matthews et al., 2003). We used 
immuno-EM to analyze CD63-enriched TEMs at the plasma 
membrane. To visualize the lateral arrangement of these 
  domains with higher spatial resolution and to determine the 
  approximate size of these domains, we used a technique that 
  allows an en face view of the cytosolic face of the plasma mem-
brane and that preserves submembrane structures such as clath-
rin lattices and cortical cytoskeleton (Sanan and Anderson, 
1991; Foti et al., 1997). After incubation with the anti-CD63 
antibody 1B5, HeLa cells, transfected or not with a CD63-YFP 
expressor plasmid, were allowed to sediment on poly-l-lysine–
coated grids. Subsequently applied hypotonic shocks, followed 
by sonication, disrupted the cells and removed the cytoplasm. 
The plasma membrane, still adherent to the grid, was processed 
for visualization by EM. Fig. 4 A shows a representative 
micrograph. It confi  rms the fl  uorescence microscopy data (Figs. 
1 and 2) by visualizing that CD63 expression at the plasma 
membrane is restricted to distinct small islands that are sepa-
rated from each other by membrane that is virtually free of this 
antigen. The size and shape of the CD63-enriched domains, as 
well as the distance between these microdomains, vary consid-
erably (mean area = 0.2 μm
2; mean distance between CD63-
enriched domains = 0.65 μm; see Table I). No signifi  cant 
differences were observed between CD63-enriched micro-
domains in cells expressing only the endogenous version of this 
tetraspanin (Fig. 4 A) and cells expressing also CD63-YFP (not 
depicted). Interestingly, many CD63 molecules appear to be sit-
uated along cytoskeletal elements and adjacent to clathrin lat-
tices and/or clathrin-coated pits.
As shown in Fig. 2 by immunofl  uorescence, despite dis-
playing an overall distribution that differs dramatically from the 
distribution of CD63, CD9 shows substantial colocalization 
with CD63 in surface TEMs. We thus sought to confi  rm the fea-
tures of surface TEMs revealed in Fig. 4 A by analyzing CD9 
clusters at the plasma membrane. Live cells were incubated 
with the anti-CD9 antibody KMC8.8, and CD9 localization was 
visualized by EM (Fig. 4 B) as described for CD63. CD9-
  containing TEMs display the same characteristics with regard 
to size and their 2D distribution within the plasma membrane 
as those enriched in CD63. Also, as expected given the fl  uores-
cence microscopy data displayed in Fig. 2 and Fig. S2, double 
labeling of cells with antibodies against CD9 and CD63 reveals 
microdomains containing one or both tetraspanins (Fig. 4, 
  compare C and D, displaying separate CD9 and CD63 clusters 
and colocalizing tetraspanins, respectively). As for the analysis 
of TEM distance (see Materials and methods), the relative
Figure 3.  Quantitative analysis of surface 
TEM composition. Cells were triple stained with 
anti-tetraspanin antibodies as described in the 
legend for Fig. 2, and the relative presence in 
surface TEMs of CD9, CD63, CD81, and 
CD82 was analyzed as described in Materials 
and methods. (A) A representative micrograph 
reveals that the relative contribution of the tet-
raspanins to the build-up of individual TEMs 
varies. (B) Statistical analyses conﬁ  rming  the 
stochastic nature of the tetraspanin contribu-
tions to TEM formation. Each bar represents a 
single TEM that showed staining for three of 
the above tetraspanins. The relative contribu-
tion of each tetraspanin was determined as 
described in Materials and methods. The bars 
were sorted in ascending order according to 
CD63 signal. Bar, 0.5 μm.TEMS CAN FUNCTION AS GATEWAYS FOR HIV-1 • NYDEGGER ET AL. 799
colocalization of the two antigens was quantifi  ed by positioning 
a grid consisting of squares with 200-nm length onto the  images. 
CD9- and CD63-associated gold particles residing in the same or 
adjacent squares were scored as colocalizing. This analysis 
  revealed that about a third (29.7 ± 4.7%; n = 20 micrographs) of 
the CD63-associated gold particles are situated proximal to CD9, 
in good agreement with the data shown in Fig. S2.
TEM positioning relative 
to HA-enriched microdomains
A recent ultrastructural study analyzed the surface distribution in 
HAb2 fi  broblasts of the infl  uenza viral envelope glycoprotein HA. 
HA, a membrane protein that is sometimes used as marker 
for fl  uid-ordered raft domains, was demonstrated to cluster at 
distinct plasma membrane microdomains if expressed indepen-
dently or together with the other viral proteins (Takeda et al., 
2003; Hess et al., 2005). To investigate the spatial relationship 
between HA and the tetraspanins CD9 and CD63, HeLa cells 
expressing HA were surface stained with the respective anti-
bodies. Fig. 5 (left) documents the 2D distribution of HA at the 
plasma membrane of these cells. As in HAb2 cells, HA is re-
stricted to discrete microdomains of variable size. Although the 
overall appearance (size and distribution) of HA clusters resem-
bles that of CD9- and CD63-containing TEMs (Fig. 5, middle), 
very little colocalization (<10%) was detected between HA and 
either CD9 or CD63 (right).
HIV-1 Gag accumulates at surface TEMs
Despite its low abundance at the plasma membrane of cells, the 
LE marker CD63 is one of few cellular antigens that are specifi  -
cally enriched in HIV-1 particles even if this virus is produced 
in cells where newly assembled particles bud primarily through 
the plasma membrane (Orentas and Hildreth, 1993; Gluschankof 
et al., 1997). We thus reasoned that HIV-1 Gag, the major 
Figure 4.  Visualization of CD63- and CD9-
enriched microdomains by immuno-EM. HeLa 
cells were incubated with either an anti-CD63 
or an anti-CD9 antibody or a combination of 
both antibodies and processed as described in 
Materials and methods. Representative elec-
tron micrographs of tetraspanin immunogold 
labeling associated with discrete membrane 
microdomains on HeLa cell plasma membrane 
are shown for cells stained for CD63 (A), CD9 
(B), or both tetraspanins (C and D). CD9- and 
CD63-associated gold particles (20 and 
10 nm, respectively) are seen by transparency. 
CD63 clusters are encircled with dashed lines 
and are marked with arrows in D; CD9 clusters 
are encircled with dotted lines, and micro-
domains containing both antigens are encircled 
by dashed/dotted lines. Bars, 0.5 μm.JCB • VOLUME 173 • NUMBER 5 • 2006  800
  structural protein of this virus, must assemble at areas of the 
plasma membrane that are enriched in CD63. The results shown 
in Fig. 6 B demonstrate that this is indeed the case. In HeLa 
cells transiently transfected with a plasmid carrying the HIV-1 
provirus and giving rise to the expression of the complete set of 
viral proteins and subsequent particle release, a large fraction of 
viral Env at the plasma membrane colocalizes with surface 
CD63 (Fig. 6 A), supporting the hypothesis that HIV-1 Gag is 
specifi   cally accumulating at these microdomains. We previ-
ously showed that, in a melanocyte cell line, about one third 
of viral Gag, the major viral structural protein, colocalizes with 
CD63 (Nydegger et al., 2003). However, unlike in the current 
analysis, in those studies we looked at total Gag and total CD63 
and thus were visualizing primarily LE/MVB-hosted CD63. 
As documented in Fig. S3 (available at http://www.jcb.org/cgi/
content/full/jcb.200508165/DC1), many of these CD63-enriched 
surface TEMs must also contain other tetraspanins because 
 signifi  cant proportions of viral Gag also colocalize with the 
  tetraspanins CD9, CD81, and CD82.
To confi   rm that viral Gag is indeed colocalizing with 
CD9- or CD63-containing TEMs at the plasma membrane and 
not, for example, at tetraspanin-enriched endosomes or MVBs 
situated right beneath the plasma membrane, we used the same 
EM technique as in Fig. 4. To achieve high expression levels for 
the viral proteins, we cotransfected cells with Gag and Env ex-
pressor plasmids, which gives rise to the production of virus-
like particles (VLPs). Fig. 7 confi  rms that tetraspanin surface 
expression is limited to distinct, often cytoskeleton-associated 
plasma membrane microdomains, as shown also in Fig. 4. 
Further, it documents that Gag can indeed associate with surface 
assemblages of either tetraspanin analyzed here. Colocalization 
analysis showed that 21.1 ± 5.0% of Gag colocalized with 
CD63-containing TEMs and 41.8 ± 4.8% of Gag colocalized 
with CD9-containing TEMs (n = 27/29 micrographs, respectively; 
TEMs were defi  ned as in Table I).
Recruitment to surface TEMs of cellular 
proteins necessary for HIV-1 
particle formation
To determine whether viral particle morphogenesis and egress 
are likely to take place at surface TEMs, we analyzed if TSG101 
and VPS28, constituents of endosomal sorting complex required 
for transport (ESCRT1) and as such known to be essential com-
ponents of the HIV-1 particle–forming machinery (Garrus et al., 
2001; Martin-Serrano et al., 2001; VerPlank et al., 2001; Demirov 
et al., 2002; Martin-Serrano et al., 2003), are recruited to Gag-
containing TEMs. Cells transfected with expressor plasmids for 
YFP-tagged TSG101 (TSG101-YFP) and CFP-tagged VPS28 
(VPS28-CFP) and cotransfected with a HIV-1 Gag expressor 
plasmid, which leads to the formation and release VLPs even in 
the absence of Env expression, were analyzed for the localiza-
tion of TSG101 and VPS28. A strong shift toward surface local-
ization was immediately apparent for both ESCRT1 components 
(Fig. 8 A and Fig. S4, available at http://www.jcb.org/cgi/ 
content/full/jcb.200508165/DC1), similar to what was previously 
observed in 293T cells producing HIV-1 (Martin-Serrano et al., 
2001). Upon closer examination, it became evident that TSG101 
and VPS28 are recruited to small but distinct Gag-containing 
patches at the plasma membrane (Fig. 8 A). To evaluate whether 
these Gag-containing microdomains are surface TEMs, cells co-
expressing HIV-1 Gag, TSG101-YFP, and FLAG-tagged VPS28 
were double stained with anti-Gag and anti-CD63 antibodies 
and were analyzed for the localization of TSG101, Gag, and 
CD63. As demonstrated in Fig. 8 B, in cells expressing HIV-1 
Gag and thus producing VLPs, a signifi  cant fraction of the 
  ESCRT1 component TSG101 relocates to the surface, where it 
colocalizes with surface CD63, strongly suggesting that surface 
TEMs can serve as sites for the production and the release of 
  viral particles. Finally, a similar recruitment to the plasma mem-
brane and colocalization with viral Gag was found for VPS28, 
another ESCRT1 component required for HIV-1 budding 
(unpublished data), providing further evidence for the notion 
that surface TEMs can provide exit gateways for HIV-1.
Association of individual viral components 
and TEMs
The data shown in Figs. 7 and 8 suggest that a considerable 
fraction of HIV-1 Gag, which can form VLPs if expressed in 
the absence of other viral components, is targeted to CD63-
 containing surface TEMs. However, as previously noted (Nydegger 
et al., 2003), Gag’s colocalization with membranes carrying the 
late endosomal markers major histocompatibility antigen type II 
Figure 5.  Distribution of surface TEMs relative to inﬂ   uenza virus HA-
  enriched microdomains. HeLa cells expressing HA were surface stained for 
HA and CD63 (A) or CD9 (B). Insets show sixfold-magniﬁ  ed views of the 
boxed region in the cell. Colocalization analysis (see Materials and methods) 
showed that 7.7 ± 5.3% of CD63 and 9.7 ± 5.8% of CD9 colocalized 
with HA. Bar, 10 μm.
Table I. Size and distribution of plasma membrane TEMs
TEM size Distance between 
individual TEMs
μm
2 μm
Endogenous CD63 only 0.19 ± 0.1 0.7 ± 0.3
Cells expressing CD63-YFP 0.22 ± 0.1 0.6 ± 0.4
Fields of plasma membrane sheets as shown in Fig. 4 A were photographed 
and analyzed for the presence of CD63 clusters, as described in Materials and 
methods (n > 50).TEMS CAN FUNCTION AS GATEWAYS FOR HIV-1 • NYDEGGER ET AL. 801
and/or CD63 is increased if it is expressed in the context of a 
full-length virus. We thus sought to quantify the colocalization 
of Gag and Env with tetraspanins if the viral proteins were ex-
pressed individually or together. Fig. 9 and Fig. S5 (available at 
http://www.jcb.org/cgi/content/full/jcb.200508165/DC1) docu-
ment that very little Env and relatively modest amounts of Gag 
colocalize with CD9- and CD63-containing surface TEMs if 
  either of the viral antigens is expressed alone. Colocalization of 
viral Gag with the two tetraspanins is barely augmented in cells 
that coexpress viral Env, whereas clearly more Env colocalizes 
with the two tetraspanins in cells cotransfected with plasmids 
carrying the gag gene. Note that TEM association of either viral 
component is most pronounced if Env and Gag are expressed 
from full-length provirus. Importantly, and in further support of 
the hypothesis that TEMs can function as egress sites, we found 
that if we restricted our analysis to the subpopulation of Gag 
that colocalizes with Env, an even higher fraction of Gag was 
found to accumulate at surface TEMs (almost 50% colocalization 
with CD63-containing TEMs and almost 70% colocalization 
with CD9-containing TEMs).
HIV-1 Env and Gag are sorted to surface 
TEMs in T lymphocytes
Though nonlymphocytes such as HeLa and 293T cells are model 
systems in which many of the cellular components of the HIV-1 
assembly/release functions were identifi  ed and characterized, it 
was necessary to determine whether viral release is routed though 
surface TEMs in T lymphocytes. However, as in HeLa cells, the 
overwhelming majority of CD63 at steady state resides in LEs/
MVBs of Jurkat T lymphocytes (Nydegger et al., 2003). Live, 
nonpermeabilized cells thus had to be stained with anti-CD63 
antibodies to visualize the distribution of this antigen in the 
plasma membrane. Fig. 10 A (left) documents that CD63 clus-
ters in plasma membrane TEMs that display sizes and overall 
distribution comparable to those analyzed in HeLa cells (Fig. 1). 
Also, as in HeLa cells, there is substantial colocalization of sur-
face CD63 and CD9. Most important, Fig. 10 (B and C) demon-
strates that virtually all HIV-1 Env expressed at the cell surface 
in the context of the full-length virus colocalizes with surface 
CD9 and surface CD63, signifying that plasma membrane TEMs 
can serve as exit gateways for HIV-1 in T lymphocytes. Judging 
by Env localization, both nonpolarized and polarized viral re-
lease was observed, the latter probably being triggered by cell–
cell contact (Phillips, 1994; Jolly et al., 2004).
Discussion
Despite its very low abundance at the cell surface, the tetra-
spanin CD63 is enriched in HIV-1 particles produced in cells 
where this virus buds primarily through the plasma membrane. 
Figure 6.  HIV-1 Env and Gag colocalize with 
surface CD63. (A) HeLa cells expressing full-
length HIV-1 were surface stained for CD63 
and HIV-1 Env. (B) To visualize Gag, cells were 
subsequently permeabilized and treated with 
an anti-Gag antibody followed by incubation 
with a ﬂ  uorophore-conjugated secondary anti-
body. Bottom sections and middle sections are 
shown for each cell. Bar, 10 μm.JCB • VOLUME 173 • NUMBER 5 • 2006  802
This prompted us to investigate whether CD63 is concentrated 
at those sites. We demonstrate that the surface fraction of CD63, 
together with other tetraspanins, clusters at discrete sites, 
thus forming surface TEMs. Besides providing a map of these 
surface TEMs, we also show that the structural components 
of HIV-1, together with elements of the host cell machinery 
  responsible for viral budding, are recruited to precisely these 
microdomains. Thus, TEMs likely function as exit gateways 
for HIV-1.
Various biochemical and functional studies have linked 
specifi  c cellular processes to the association of distinct proteins 
and tetraspanins. However, few studies have also analyzed the 
localization of tetraspanins involved in these processes, and 
physical aspects of TEMs, particularly size and distribution of 
these microdomains, have remained enigmatic. We hypothe-
sized that CD63-enriched microdomains exist at the cell surface 
despite the fact that this tetraspanin is a resident primarily of 
LEs/MVBs. Fig. 1 documents for HeLa cells that this is indeed 
the case. These surface microdomains at fi  rst sight appear mor-
phologically featureless; i.e., they are not restricted to pseudo-
pods, for example, but they are distributed over the entire plasma 
membrane. The same holds for the other three tetraspanins 
  analyzed in this study. Not only do they colocalize to a signifi  -
cant extent with CD63, surface TEMs containing these other 
tetraspanins are also spread over the entire cell surface and are 
not apparently engaged in any adhesion/migration-related func-
tions (Fig. 2), though, as noted below, they clearly appear to 
be   enriched in microvilli.
Size and 2D distribution of plasma 
membrane TEMs
To confi  rm the distribution pattern visualized by fl  uorescence 
microscopy and to get information about the size of surface 
TEMs, we used an immuno-EM technique that we had applied 
before and that allowed us to look perpendicularly with respect to 
the plane of the plasma membrane (Sanan and Anderson, 1991; 
Foti et al., 1997). Although the majority of the plasma membrane 
appeared devoid of CD63 and CD9, distinct clusters of these two 
antigens can be found dispersed over the entire cell surface. 
As integral membrane proteins, CD9 and CD63 arrive at the cell 
surface on vesicles that are inserted into the plasma membrane. 
The fi  nding that all the TEMs analyzed in this study (Figs. 1–4) 
are separated from each other by areas that are virtually free of 
these antigens suggests that the four tetraspanins, rather than dif-
fusing in the 2D plane, stay clustered in small areas that cover 
only a relatively small fraction of the membrane. Even though 
TEMs are immediately recognizable as distinct microdomains, 
size, shape, and the relative presence of the four tetraspanins in 
these domains varies substantially, as is evident in Figs. 2–4 and 7. 
Whether the larger domains visualized here represent clusters of 
smaller base units or whether TEMs grow continuously until they 
reach a maximal size remains to be analyzed. Finally, though 
these domains appear uniformly distributed within the plasma 
membrane, our ultrastructural analysis of plasma membrane 
sheets (Figs. 4 and 7) reveals that TEMs form preferentially at 
or adjacent to clathrin-coated areas and next to elements of the 
  cytoskeleton. The former feature clearly sets them apart from 
HA-enriched microdomains, which are situated in membrane areas 
free of clathrin-coated pits (Hess et al., 2005).
TEM biogenesis
Recent studies in rodent cells have suggested that CD63, upon 
synthesis, is sorted directly to LEs/MVBs, where most of this 
antigen resides (Rous et al., 2002; Ihrke et al., 2004), though 
some of the newly synthesized protein may be sorted via the 
plasma membrane. Fluorescence microscopy and ultrastructural 
analyses of secretory lysosomes and MVBs, respectively (Murk 
et al., 2003; Jaiswal et al., 2004), suggested that proteins are not 
uniformly distributed within the limiting membrane of these 
LEs/MVBs. Data presented in one of these studies (Jaiswal et al., 
2004) are compatible with the possibility that CD63 is clustered 
within distinct microdomains of the limiting membrane. It would 
thus be conceivable that TEMs nucleate in the limiting mem-
brane of endosomes/secretory lysosomes and become part of the 
plasma membrane after these compartments have moved to 
the cell surface and the limiting membrane has been inserted into 
the plasma membrane. Alternatively, signifi  cant fractions of newly 
synthesized LE/lysosomal markers lamp1, lamp2, and CD63 
  appear to be sorted via the plasma membrane before reaching 
their fi  nal destination in HeLa cells (Janvier and Bonifacino, 
2005). Insertion of post-Golgi vesicles into the plasma membrane 
may thus contribute to the formation of surface TEMs.
TEMs roles in viral egress
Two lines of evidence in our current study suggest that surface 
TEMs can serve as exit gateways for HIV-1. First, most cell 
Figure 7.  Immuno-EM analysis of HIV-1 Gag accumulation at surface 
TEMs containing CD9 or CD63. HeLa cells were incubated with either an 
anti-CD63 or an anti-CD9 antibody, and cells were treated as described 
for Fig. 4. CD9- and CD63-associated gold particles (10 nm) and Gag-
  associated gold particles (15 nm) are seen by transparency. Representative 
electron micrographs of HIV-1 Gag immunogold labeling associated with 
discrete plasma membrane microdomains are shown for cells stained for 
either CD63 or CD9. Bar, 0.2 mm.TEMS CAN FUNCTION AS GATEWAYS FOR HIV-1 • NYDEGGER ET AL. 803
surface punctae where either Gag or Env clusters in both HeLa 
cell and in Jurkat T lymphocytes are also occupied by one of the 
tetraspanins (Figs. 6–8 and 10). Second, cellular TSG101 and 
VPS28, the components of the cellular budding machinery re-
sponsible for viral egress (Morita and Sundquist, 2004), when 
recruited to the plasma membrane in cells producing HIV-1, ac-
cumulate at CD63-containing TEMs (Fig. 8). Furthermore, we 
fi  nd that distortion of TEM distribution in virus-producing cells 
by an anti-CD9 antibody (K41) correlates with inhibition of 
HIV-1 release (unpublished data).
In a study where we used the FlAsH technique for succes-
sive dual-color labeling (Gaietta et al., 2002) of Gag in various 
virus-secreting cell types, we observed localization of newly 
synthesized Gag at distinct areas on the plasma membrane 
(Rudner et al., 2005). We also documented that viral budding 
structures and CD63 colocalize at MVBs and at the surface of 
HeLa cells (Nydegger et al., 2003). Based on this latter fi  nding 
and on the relatively large size (1–4 μm) of patches at the 
plasma membrane through which the virus appeared to bud in 
this preceding, lower resolution study, we hypothesized that the 
microdomains through which HIV-1 buds are derivatives of LE/
MVB limiting membrane (see above). However, the results pre-
sented in Figs. 6–8 indicate that the large patches observed in 
our previous studies may indeed have been clusters of smaller, 
Figure 8.  TSG101 and VPS28 are recruited 
to CD63-containing surface TEMs where Gag 
clusters. (A) HeLa cells expressing HIV-1 Gag, 
TSG101-YFP, and VPS28-CFP were ﬁ  xed, per-
meabilized, and stained for Gag. (B) HeLa 
cells expressing HIV-1 Gag, TSG101-GFP, and 
FLAG-VPS28 were ﬁ   xed, surface stained for 
CD63, permeabilized, and stained for Gag. 
Bottom sections are shown for each cell. 
Blow-ups show 11-fold–magniﬁ  ed views of the 
boxed region in the cell. Bar, 10 μm.
Figure 9.  Quantitative analysis of viral Env and Gag 
  colocalization with tetraspanins. HeLa cells expressing HIV 
Gag and Env individually, together but expressed from 
different plasmids, or coexpressed from a proviral vector 
were incubated with anti-Env and anti-CD63 (A) or anti-
CD9 (B) antibodies without permeabilization. After ﬁ  xa-
tion, the cells were permeabilized and incubated with an 
anti-Gag antibody and with ﬂ  uorophore-conjugated sec-
ondary antibodies. Fluorescent images were captured and 
analyzed for colocalization (see Materials and methods). 
At least 10 cells were analyzed for each condition. The 
bar diagrams summarize the data from that analysis. 
The percentage of Gag or Env that colocalizedwith either 
CD63 or CD9 is shown. White bars show Gag or Env colocalization with CD63 or CD9 if the viral antigens were expressed separately, gray bars show 
Gag or Env colocalization with CD63 or CD9 if the viral antigens were coexpressed from separate plasmids, and black bars show Gag or Env colocalization 
with CD63 or CD9 if the viral antigens were coexpressed from a proviral plasmid. Error bars indicate SD.JCB • VOLUME 173 • NUMBER 5 • 2006  804
possibly post-Golgi vesicle-derived TEMs that form supraclus-
ters in cells producing virus (Figs. 6 and 8 and Fig. S3).
Although it is well documented that HIV-1 exit from cells 
is restricted to distinct areas of the cell cortex, it remained un-
clear which of the viral components is the primary determinant 
that targets release to these sites. A fl  uorescence microscopy 
analysis demonstrated that Gag recruits Env to distinct areas at 
the plasma membrane (Hermida-Matsumoto and Resh, 2000). 
Consistent with this paper, we show that Gag has intrinsic TEM 
targeting information as it colocalizes with TEMs if expressed 
alone (Fig. 9) and thus codetermines where HIV-1 buds. Never-
theless, Gag colocalizes more extensively with surface tetraspa-
nins if Env is coexpressed (Figs. 6 and 9 and Fig. S5), and Env 
thus plays at least a modulatory role in determining where HIV-1 
exits from cells.
Biochemical studies (Rousso et al., 2000; Lindwasser and 
Resh, 2001; Ono and Freed, 2001) and a fl  uorescence micros-
copy analysis in T lymphocytes, where HIV-1 was shown to exit 
at the same pole where the raft marker GM1 accumulates 
(Nguyen and Hildreth, 2000), suggested that lipid rafts or barges 
are critical for HIV-1 exit. On the other hand, it was also re-
ported that Gag complexes, defi  ned by fl  otation studies, do not 
incorporate classical lipid raft markers and were not disrupted 
by cholesterol extraction (Ding et al., 2003). Further, as  reviewed 
recently elsewhere, rafts probably have many different prop-
erties, and these lipid-based microdomains remain diffi  cult 
to defi  ne (Edidin, 2003; Mukherjee and Maxfi  eld, 2004). 
  Nevertheless, the two hypotheses, i.e., that rafts are important 
during HIV-1 assembly and that TEMs serve as viral exit gate-
ways, are not mutually exclusive. Rafts, for example, could 
  potentially form and/or coalesce during viral budding at TEMs. 
However, as recently noted (Yang et al., 2004), though tetraspanins 
are palmitoylated, a proteomics analysis of lipid rafts did 
not reveal any tetraspanins or integrins, nor were typical raft 
proteins found in a mass spectrometry analysis to be partners 
for tetraspanins and palmitoylated integrins (Foster et al., 2003; 
Yang et al., 2004). Also, HA-containing rafts (Hess et al., 2005) 
for the most part do not colocalize with TEMs containing CD9 
and/or CD63 in HeLa cells, as documented in Fig. 5.
Although this study provides evidence for the concept that 
surface TEMs can serve as HIV-1 exit sites, we are currently in-
vestigating whether the viral components can also be endo-
cytosed via these domains. The concept that viral components 
may be sequestered in the endosomal compartment to be mobi-
lized for virion formation later, e.g., upon attachment to a target 
cell, was fi  rst discussed by Rodriguez-Boulan et al. (1983). The 
positioning of TEMs adjacent to clathrin-coated areas (Figs. 
4 and 7), together with various reports about the itineraries of 
CD63 as well as HIV-1 Gag and Env (Blot et al., 2003; Lind-
wasser and Resh, 2004; Murray et al., 2005), are compatible 
with such a scenario.
In summary, data presented in this paper provide a map of 
surface TEMs and demonstrate that these domains constitute 
sites at which HIV-1 proteins gather for potential subsequent 
particle exit. TEMs have been implicated in coordinating func-
tions at the cell–cell interface. It is thus conceivable that HIV-1 
evolved to egress through these microdomains to ensure effi  -
cient release toward adjacent target cells.
Materials and methods
Cell culture, plasmids, and transfections
HeLa and Jurkat cells were grown in DME or RPMI (Invitrogen), respec-
tively, supplemented with 10% FBS (Invitrogen). Transfections were per-
formed using Lipofectamine 2000 (Invitrogen) or by electroporation 
(Bio-Rad Laboratories) according to the manufacturers’ protocol.
The following plasmids were used: pNL4-3, pGagopt (a gift from 
D. Ott, National Cancer Institute at Frederick, Frederick, MD), pSRalpha-Env, 
pVPS28-CFP, pTSG101-YFP (a gift from P. Bienasz, The Rockefeller Univer-
sity, New York, NY), pTSG101-GFP, pFLAG-VPS28 (a gift from U. von 
Schwedler and W. Sundquist, University of Utah, Salt Lake City, UT), 
pCD82-YFP (a gift from W. Mothes, Yale University School of Medicine, 
New Haven, CT), and pCD63-YFP (a gift from J. Bonafacino, National 
  Institutes of Health, Bethesda, MD). Analysis of cells was performed 24 h 
after transfection with pGagopt or pSRalpha-Env alone or when cotrans-
fected with pGagopt, pSRalpha-Env, pVPS28-CFP, pFLAG-VPS28, or 
pTSG101-GFP/YFP, and after 30–48 h when transfected with pNL4-3.
Immunocytochemistry and ﬁ  xed cell imaging analysis 
by ﬂ  uorescence microscopy
Adherent cells were plated in chambered coverglasses (Lab-Tek; Nunc) or 
in 35-mm glass-bottomed culture dishes (MatTek). Transfection and staining 
were performed directly in these chambers.
The following antibodies were used: anti-CD9 (K41; BMA Biomedi-
cals AG); anti-CD63 (H5C6; Developmental Studies Hybridoma Bank); anti-
CD63 clone 1B5 (a gift from J. Gruenberg [University of Geneva, Geneva, 
Figure 10.  HIV-1 at surface TEMs in Jurkat T lymphocytes. Jurkat T lym-
phocytes were surface stained for CD9 and CD63 (A). Surface TEMs con-
taining CD9 and CD63 are comparable in size, and their distribution is 
similar to the one in HeLa cells (Fig. 2). (B and C) Jurkat T lymphocytes 
transfected with HIV-1 provirus–carrying plasmids and thus producing in-
fectious virus were surface stained for Env and CD63 or CD9 to visualize 
virus and surface TEMs, respectively. Bar, 5 μm.TEMS CAN FUNCTION AS GATEWAYS FOR HIV-1 • NYDEGGER ET AL. 805
Switzerland] and M. Marsh [University College London, London, UK]); 
anti-CD81 (JS-81; BD Biosciences); anti-CD82 (B-L2; Diaclone); anti-Env 
(B12; NIH AIDS Research & Reference Reagent Program); anti-p6 (AIDS 
Vaccine Program, National Cancer Institute); anti-VPS28 serum; anti-HA 
rabbit serum (gift from M. Roth, The University of Texas Southwestern Medi-
cal Center, Dallas, TX); anti-mouse Alexa Fluor 488, 594, and 647; anti-
rabbit Alexa Fluor 488, 594, and 647; and anti-human Alexa Fluor 488 
and 594 (Invitrogen).
The slides were examined on a Delta Vision (DV) Workstation (DV 
base 3/3.5; epiﬂ   uorescence microscope [Eclipse TE200; Nikon] ﬁ  tted 
with an automated stage [Applied Precision, Inc.]) using a Plan Apo 60× 
objective (Nikon), 1.40 NA. Images were captured in z series with a 
charge-coupled device digital camera (CH350E or CoolSnap HQ [Roper 
Scientiﬁ  c]) using the DV Softworx software. Out-of-focus light was digitally 
removed using Softworx deconvolution software (Applied Precision Inc.), 
using the standard DV iterative deconvolution algorithm. Levels on each 
channel were adjusted in the DV Softworx software, and z sections of inter-
est were exported as Tiff ﬁ  les. Tiffs were assembled into ﬁ  gures using 
  Photoshop (Adobe).
Quantiﬁ  cation of colocalization was computed using the Classiﬁ  er 
Module of the Volocity Software 3.1 (Improvision). The bottom sections of 
representative cells were analyzed. Fluorescence thresholds for individual 
channels were set to two times the standard deviation of the signal, and the 
ﬂ  uorescence intensity of each pixel was measured. Colocalization percent-
ages were calculated by dividing the total number of pixels with intensity 
above the threshold that overlapped between two channels by the total 
number of pixels with intensity above the threshold for a given channel.
The relative contributions of tetraspanins to the formation of TEMs 
was assessed by selecting ﬂ   uorescence thresholds for each channel fol-
lowed by counting the individual clusters of each tetraspanin to gauge the 
presence or absence of one, two, or all three channels in a given cluster. 
The relative contributions of tetraspanins to the formation of triple TEMs 
(Fig. 3) was calculated by selecting TEMs containing signal for three tetra-
spanins and quantifying the relative intensity and area of each channel in 
a given TEM.
Overall staining
Cells were washed with PBS and ﬁ   xed with 3.7% paraformaldehyde 
(Electron Microscopy Sciences) for 10 min at room temperature. After 
washing with PBS, cells were permeabilized with 0.2% Triton X-100 in PBS 
for 10 min, washed again, and blocked with 1% BSA in PBS for 10 min, fol-
lowed by a 1-h incubation with primary antibody at 37°C. After extensive 
washing with PBS, cells were blocked again with 1% BSA in PBS for 10 min 
and then incubated with the appropriate ﬂ  uorophore-conjugated second-
ary antibody for 30 min. After extensive washing with PBS, cells were 
overlaid with 1% BSA in PBS and examined by ﬂ  uorescence microscopy.
In case multiple antibodies of the same species were used, the anti-
bodies were conjugated with a ﬂ  uorophore using the Zenon technology 
according to the manufacturer’s protocol (Invitrogen) before incubation 
with cells. Also, we routinely incubate cells with no, or only one (in dual 
stainings) or two (in triple stainings), primary antibodies, to control for non-
speciﬁ  c binding of the secondary antibodies.
Surface staining
Cells were washed with PBS and ﬁ  xed with 3.7% paraformaldehyde for 
10 min. Without permeabilization, cells were incubated for 1 h with pri-
mary antibody at 37°C in 1% BSA in PBS. Alternatively, live cells were 
precooled on ice and incubated for 1 h on ice at 4°C with primary anti-
body in complete medium supplemented with 1% Ca
2+. Cells were then 
washed extensively with PBS and ﬁ  xed for 10 min with 3.7% paraformal-
dehyde. After washing with PBS, cells were blocked for 10 min with 1% 
BSA in PBS and incubated with the appropriate ﬂ  uorophore-conjugated 
secondary antibody for 30 min at room temperature. After extensive washing 
with PBS, cells were overlaid with 1% BSA in PBS and examined by ﬂ  uo-
rescence microscopy.
If two different surface stainings were performed on the same cells, 
both primary antibodies were added at the same time, followed by 
ﬂ   uorophore-conjugated secondary antibody incubation. In case surface 
staining was followed by an overall staining, cells were permeabilized 
subsequently and treated with primary antibody followed by ﬂ  uorophore-
conjugated secondary antibody as described above.
Surface staining of Jurkat T lymphocytes
Jurkat cells were washed with PBS and incubated in suspension for 1 h on 
ice at 4°C with primary antibody in complete medium supplemented with 
1% Ca
2+. The cells were then washed with PBS and ﬁ  xed with 3.7% para-
formaldehyde for 10 min. The cells were washed, blocked for 10 min in 
1% BSA in PBS, and transferred to chambered coverglasses precoated 
with CellTak (BD Biosciences) and incubated with the secondary antibodies 
at 37°C, simultaneously immobilizing the cells on the coverglass. In case 
multiple antibodies of the same species were used, the antibodies were 
conjugated with a ﬂ  uorophore using the Zenon technology, and the stain-
ings were done in series.
EM analysis
CD63- or CD9-enriched microdomains were visualized at the EM ultra-
structural level on the inner face of the plasma membrane of HeLa cells as 
previously described (Sanan and Anderson, 1991; Foti et al., 1997). 
In brief, HeLa cells were incubated for 1 h at 4°C with either anti-CD63 
  antibodies (clone 1B5 of mouse anti-CD63 IgG2b [Fraile-Ramos et al., 2001] 
and antibody H5C6) or anti-CD9 antibodies (clone KMC8.8 of rat anti-
CD9 [Santa Cruz Biotechnotolgy, Inc.] or K41 [Bachem]) in cold 1% BSA 
in PBS. After antibody binding, cells were washed twice in cold PBS to 
  remove excess antibody and incubated with secondary species-speciﬁ  c 
gold-conjugated antibodies (10- or 20-nm colloidal gold) for 1 h at 4°C. 
Unbound secondary antibody was removed by washing twice with cold 
PBS. Cells were detached from the Petri dishes and allowed to sediment on 
formvar-coated EM nickel grids previously coated with poly-L-lysine. Adher-
ent isolated plasma membranes were obtained by incubating the cells at-
tached to the grids with hypotonic (0.65×) PBS for 30 s and then sonicating 
the cells at a weak power. This procedure disrupts the cells but allows a 
large portion of plasma membranes with conserved internal structures, 
such as clathrin-coated membranes and cytoskeleton elements, to stay 
adherent to the poly-L-lysine–coated grids. Adherent membranes were 
next washed with cold PBS and preﬁ  xed for 15 min at 4°C with 1% N-
(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride/0.2% glutar-
aldehyde, followed by 15 min at room temperature with 4% glutaraldehyde 
in PBS. Adherent membranes were subsequently ﬁ  xed in 2% osmium tetrox-
ide in PBS for 8 min and 30 s at room temperature, washed three times 
for 5 min with PBS, incubated with 1% aqueous tannic acid for 10 min, 
washed twice for 5 min in distilled water, incubated with 1% uranyl acetate 
for 10 min, and washed twice for 1 min with distilled water before air-drying. 
For CD63–CD9 double-labeling experiments, CD63 gold labeling was 
performed as described above, but CD9 was localized using a rabbit 
polyclonal anti-CD9 antibody (clone H-110; Santa Cruz Biotechnology, 
Inc.). Membranes considered well conserved were then photographed on 
an electron microscope (CM10; Philips). The mean size of CD63-enriched 
microdomains, as well as the mean distance separating these domains, 
was determined by analyzing 23 EM micrographs illustrating >50 well-
delimited CD63-enriched microdomains. For this analysis, a grid consist-
ing of squares with 200-nm length was positioned onto the images, and 
the numbers of gold particles per square were evaluated. Adjacent squares 
containing a sum of at least ﬁ  ve particles were considered one TEM, and 
the mean size of these domains was calculated. The mean distance be-
tween TEMs was calculated by measuring the distances between the outer-
most squares deﬁ  ning the individual TEMs. To quantify either colocalization 
of CD63 and CD9 (Fig. 4) or Gag and tetraspanins (Fig. 7), the numbers 
of tetraspanin-associated gold particles situated either within the same 
square or in adjacent squares were determined (Fig. 4), or the numbers of 
Gag-associated gold particles overlapping with or directly adjacent to 
TEMs (as deﬁ  ned above) were determined. The percentages ± SEM are 
listed in the Results section.
For immunogold labeling of ultrathin cryosections, cells were de-
tached and ﬁ  xed for 1 h in phosphate buffer (100 mM NaPO4, pH 7.4) 
containing 4% paraformaldehyde (EMS) and 0.1% glutaraldehyde 
(EMS). Thereafter, the ﬁ  xative was rinsed out three times with phosphate 
buffer and the cells were processed for cryosectioning as described pre-
viously (Liou et al., 1996). In brief, the cell pellet was inﬁ  ltrated with su-
crose and frozen in liquid nitrogen. Frozen sections (45-nm thickness) 
were cut with a cryotome (FCS; Leica), transferred to grids, and incu-
bated with antibodies against CD63 (clone 1B5 of mouse anti-CD63 
IgG2b). Grids were examined with a transmission electron microscope 
(Tecnai G-12; FEI Company).
Online supplemental material
Fig. S1 shows the overall distribution of the tetraspanins CD9, CD81, 
CD82, and CD63 when the cells were stained for only one of the anti-
gens or dual labeled for two tetraspanins. Fig. S2 identiﬁ  es surface TEMs 
containing two tetraspanins. Fig. S3 documents accumulation of viral Gag 
at plasma membrane TEMs containing CD9, CD81, or CD82. Fig. S4 JCB • VOLUME 173 • NUMBER 5 • 2006  806
demonstrates that TSG101 and VPS28, rather than accumulating at sur-
face TEMs, are concentrated at intracellular compartments throughout the 
cell in the absence of viral Gag expression. Fig. S5 provides an immuno-
ﬂ  uorescence analysis of viral Env and Gag colocalization with tetraspa-
nins representative of some of the data shown in Fig. 9. Video 1 shows 
untransfected HeLa cells that were surface stained for CD63, as described 
in Fig. 1. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200508165/DC1.
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